{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:51:28Z","timestamp":1791755488642,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014088","name":"AstraZeneca SAS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resmer.2025.101187","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T02:44:49Z","timestamp":1754448289000},"page":"101187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessment of cardiopulmonary risk in COPD patients: Expert opinion formalized using the Delphi method"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-5033","authenticated-orcid":false,"given":"Nicolas","family":"Roche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"Zysman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Deslee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Kownator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"Lamia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cohen-Solal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2025.101187_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S2213-2600(12)70060-7","article-title":"Chronic obstructive pulmonary disease and comorbidities","volume":"1","author":"Decramer","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resmer.2025.101187_bib0002","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s12325-024-02855-4","article-title":"Implications of cardiopulmonary risk for the management of COPD: a narrative review","volume":"41","author":"Singh","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.resmer.2025.101187_bib0003","unstructured":"Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2024 report n.d."},{"key":"10.1016\/j.resmer.2025.101187_bib0004","article-title":"Chronic obstructive pulmonary disease (COPD)","year":"2023","journal-title":"Chronic obstructive pulmonary disease (COPD) (who.int)"},{"key":"10.1016\/j.resmer.2025.101187_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/2045-8932.109910","article-title":"Pulmonary Heart disease: the heart-lung interaction and its impact on patient phenotypes","volume":"3","author":"Forfia","year":"2013","journal-title":"Pulm Circ"},{"key":"10.1016\/j.resmer.2025.101187_bib0006","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14779072.2024.2333786","article-title":"Cardiovascular disease and risk in COPD: a state of the art review","volume":"22","author":"Polman","year":"2024","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.resmer.2025.101187_bib0007","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/S2468-2667(23)00269-4","volume":"9","author":"Groenewegen","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.resmer.2025.101187_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001307","article-title":"Sex-specific and age-specific incidence of ischaemic heart disease, atrial fibrillation, and heart failure in community patients with chronic obstructive pulmonary disease","volume":"9","author":"Groenewegen","year":"2022","journal-title":"BMJ Open Resp Res"},{"key":"10.1016\/j.resmer.2025.101187_bib0009","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/eurheartj\/ehad669","article-title":"Exacerbating the burden of cardiovascular disease: how can we address cardiopulmonary risk in individuals with chronic obstructive pulmonary disease?","volume":"45","author":"Shrikrishna","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.resmer.2025.101187_bib0010","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.202307-1122OC","article-title":"Temporal risk of nonfatal cardiovascular events after chronic obstructive pulmonary disease exacerbation: a population-based study","volume":"209","author":"Graul","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101187_bib0011","volume":"2019","year":"2014"},{"key":"10.1016\/j.resmer.2025.101187_bib0012","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.arbres.2024.01.013","article-title":"Multidisciplinary management of patients with chronic obstructive pulmonary disease and cardiovascular disease","volume":"60","author":"De Miguel-D\u00edez","year":"2024","journal-title":"Archivos de Bronconeumolog\u00eda"},{"key":"10.1016\/j.resmer.2025.101187_bib0013","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"WJM"},{"key":"10.1016\/j.resmer.2025.101187_bib0014","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.amjcard.2021.02.042","article-title":"The cardiovascular physical examination \u2013 Is it still relevant?","volume":"149","author":"Lekic","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.resmer.2025.101187_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ehjci\/jet195","article-title":"The decline of our physical examination skills: is echocardiography to blame?","volume":"15","author":"Roelandt","year":"2014","journal-title":"Eur Heart J - Cardiovascular Imaging"},{"key":"10.1016\/j.resmer.2025.101187_bib0016","first-page":"255","article-title":"Hyposkillia: deficiency of clinical skills","volume":"32","author":"Fred","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.resmer.2025.101187_bib0017","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.rmr.2017.03.001","article-title":"Prise en charge des exacerbations de la bronchopneumopathie chronique obstructive (BPCO). Recommandations de la Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise (Argumentaire)","volume":"34","author":"Jouneau","year":"2017","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.resmer.2025.101187_bib0018","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.resmer.2025.101187_bib0019","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Hageman","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.resmer.2025.101187_bib0020","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/eurheartj\/ehv121","article-title":"Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study","volume":"36","author":"Lahousse","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.resmer.2025.101187_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rmra.2023.11.043","article-title":"Exacerbations de bronchopneumopathie chronique obstructive et \u00e9v\u00e8nements cardiovasculaires\u202f: analyses descriptives des donn\u00e9es du PMSI","volume":"16","author":"Zysman","year":"2024","journal-title":"Revue des Maladies Respiratoires Actualit\u00e9s"},{"key":"10.1016\/j.resmer.2025.101187_bib0022","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/heartjnl-2023-323487","article-title":"Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease","volume":"110","author":"Hawkins","year":"2024","journal-title":"Heart"},{"key":"10.1016\/j.resmer.2025.101187_bib0023","article-title":"Cartes de France de l\u2019acc\u00e8s aux soins","author":"Vigneron","year":"2024","journal-title":"Soignants et patients face aux in\u00e9galit\u00e9s territoriales"},{"key":"10.1016\/j.resmer.2025.101187_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.201203-0455PP","article-title":"The relationship between lung inflammation and cardiovascular disease","volume":"186","author":"Van Eeden","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101187_bib0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/jcm8010069","article-title":"Cardiovascular comorbidities in chronic obstructive pulmonary disease (COPD)\u2014Current considerations for clinical practice","volume":"8","author":"Trinkmann","year":"2019","journal-title":"JCM"},{"key":"10.1016\/j.resmer.2025.101187_bib0026","article-title":"C-reactive protein as a predictor of severity in chronic obstructive pulmonary disease: an experience from a tertiary care hospital","author":"Hassan","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.resmer.2025.101187_bib0027","article-title":"Association between urinary albumin creatinine ratio and cardiovascular disease","volume":"18","author":"Kim","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.resmer.2025.101187_bib0028","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1210\/clinem\/dgad645","article-title":"Association of urine albumin to creatinine ratio with cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"109","author":"Zeng","year":"2024","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.resmer.2025.101187_bib0029","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00160213","article-title":"COPD and microalbuminuria: a 12-year follow-up study","volume":"43","author":"Romundstad","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101187_bib0030","doi-asserted-by":"crossref","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Rapport d\u2019\u00e9valuation technologique \u2013 Service Evaluation des actes professionnels : evaluation du rapport albuminurie \/cr\u00e9atininurie dans le diagnostic de la maladie r\u00e9nale chronique chez l\u2019adulte. 2011 n.d.","DOI":"10.1007\/s11834-011-0066-4"},{"key":"10.1016\/j.resmer.2025.101187_bib0031","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2018","article-title":"Cardiovascular disease and COPD: dangerous liaisons?","volume":"27","author":"Rabe","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resmer.2025.101187_bib0032","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2006.04.039","article-title":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease","volume":"47","author":"Mancini","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.resmer.2025.101187_bib0033","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa1403086","article-title":"Simvastatin for the prevention of exacerbations in moderate-to-severe COPD","volume":"370","author":"Criner","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2025.101187_bib0034","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pupt.2017.03.001","article-title":"Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: a sub-analysis of GISSI-HF trial","volume":"44","author":"Rossi","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.resmer.2025.101187_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2025.101187_bib0036","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1164\/rccm.201911-2207OC","article-title":"Reduction in all-cause mortality with Fluticasone Furoate\/umeclidinium\/vilanterol in patients with chronic obstructive pulmonary disease","volume":"201","author":"Lipson","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101187_bib0037","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pulmoe.2018.09.006","article-title":"COPD and cardiovascular disease","volume":"25","author":"Andr\u00e9","year":"2019","journal-title":"Pulmonology"},{"key":"10.1016\/j.resmer.2025.101187_bib0038","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1164\/rccm.201604-0690SO","article-title":"Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care","volume":"194","author":"Roversi","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101187_bib0039","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1007\/s12325-023-02609-8","article-title":"Implementing an evidence-based COPD hospital discharge protocol: a narrative review and expert recommendations","volume":"40","author":"Miravitlles","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.resmer.2025.101187_bib0040","doi-asserted-by":"crossref","DOI":"10.5334\/ijic.ICIC23161","article-title":"Development and implementation of an integrated pharmaceutical care program for patients with COPD in a Rehabilitation Hospital","author":"Wuyts","year":"2023","journal-title":"Int J Integr Care"},{"key":"10.1016\/j.resmer.2025.101187_bib0041","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41591-024-02905-y","article-title":"Development and validation of a new algorithm for improved cardiovascular risk prediction","volume":"30","author":"Hippisley-Cox","year":"2024","journal-title":"Nat Med"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:40:07Z","timestamp":1763829607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041225000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"alternative-id":["S2590041225000340"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101187","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of cardiopulmonary risk in COPD patients: Expert opinion formalized using the Delphi method","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101187"}}